We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 8,258

Pharmaceutical marketing and unfair-trade-practices claims
  • Ellis & Winters
  • USA
  • May 26 2015

Lawsuits against pharmaceutical companies generally center on product-liability claims. A new trend in pharma cases, however, is to include a


Top antitrust enforcers respond to congressional questioning
  • McDermott Will & Emery
  • USA
  • May 26 2015

Federal Trade Commission (FTC) Chairwoman Edith Ramirez and Assistant Attorney General William Baer testified before the House Committee on the


Anatomy of a provider-merger antitrust challenge (part 6)
  • Ober Kaler
  • USA
  • May 25 2015

This is the concluding installment of a six-part series discussing the Federal Trade Commission's challenges to provider mergers. Following the


Unsealed False Claims Act suit asserts that reverse payment settlements create government overpayments
  • Arent Fox LLP
  • USA
  • May 22 2015

Pharmaceutical manufacturers could face a new line of attack related to Hatch-Waxman reverse payment settlement agreements (so-called


Foreign Trade Antitrust Improvements Act. Foreign application of U.S. antitrust laws. Seventh Circuit affirms summary judgment against Motorola denying its efforts to apply U.S. antitrust law over foreign transactions between Defendants and Motorola’s foreign subsidiaries
  • Baker & McKenzie
  • USA
  • May 21 2015

Motorola Mobility LLC (“Motorola”) sued Samsung, Sanyo, AU Optronics Corp. and several other foreign LCD screen manufacturers in the district court


State regulatory scheme offering antitrust immunity to healthcare collaborations creates tension between federal and state antitrust enforcement
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • May 20 2015

On April 22, 2015, the Federal Trade Commission submitted a public letter to the New York State Department of Health (DOH) expressing "strong


The U.S. Supreme Court's decision in North Carolina Dental Board: what state attorneys general need to know about antitrust immunity for state licensing boards
  • Venable LLP
  • USA
  • May 20 2015

On February 25, 2015, the U.S. Supreme Court (Court) issued its opinion in North Carolina State Board of Dental Examiners v. Federal Trade Commission


Who should regulate healthcare competition? The New York COPA dispute
  • Manatt Phelps & Phillips LLP
  • USA
  • May 20 2015

In last month’s Antitrust Update, we reported on the conflict between Georgia’s Certificate of Need laws and the Federal Trade Commission’s (FTC’s


Crowley executive acquittal in price fixing trial highlights importance of evaluating legitimate defenses and avoiding costly plea agreements
  • Cadwalader Wickersham & Taft LLP
  • USA
  • May 18 2015

A federal jury's recent acquittal of a shipping company executive charged with price fixing highlights the challenges and uncertainties the Antitrust


Cartel watch (volume 3, issue 2)
  • Weil Gotshal & Manges LLP
  • European Union, South Korea, USA
  • May 18 2015

In this issue of Cartel Watch, we continue our coverage of notable developments in U.S. and international cartel enforcement and provide our Cartel